These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17924256)

  • 21. Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
    Sarotar BN; Pesek MB; Agius M; Pregelj P; Kocmur M
    Psychiatr Danub; 2008 Jun; 20(2):179-83. PubMed ID: 18587288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of outcome in first-episode schizophrenia over the first 4 years of illness.
    Whitty P; Clarke M; McTigue O; Browne S; Kamali M; Kinsella A; Larkin C; O'Callaghan E
    Psychol Med; 2008 Aug; 38(8):1141-6. PubMed ID: 18447960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognosis of the effectiveness of pharmacotherapy of patients with acute schizophrenia based on a correlation and regression analysis of clinical and electroencephalographic indices].
    Nemtsov AV; Kalinin VV; Zaĭtsev SG; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep; 82(9):68-73. PubMed ID: 6128846
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines.
    Lass J; Männik A; Bell JS
    J Clin Pharm Ther; 2008 Apr; 33(2):165-73. PubMed ID: 18315782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
    Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
    Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of a community intervention for early identification of first-episode psychosis.
    Cassidy CM; Schmitz N; Norman R; Manchanda R; Malla A
    Acta Psychiatr Scand; 2008 Jun; 117(6):440-8. PubMed ID: 18479319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A patient with a prolonged untreated psychosis].
    Neven A; Klaassen MC
    Tijdschr Psychiatr; 2009; 51(1):59-63. PubMed ID: 19194847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical aspects of schizophrenia].
    Versaevel C
    Soins Psychiatr; 2007; (249):18-23. PubMed ID: 17438981
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving outcomes for patients with schizophrenia: new hope for an old illness.
    Seeman MV
    CMAJ; 1999 Mar; 160(6):826-8. PubMed ID: 10189430
    [No Abstract]   [Full Text] [Related]  

  • 32. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of psychotropic drugs in the insidious deconstruction of the Kraepelinian dichotomy.
    Vinar O
    Psychiatr Danub; 2007 Dec; 19(4):354-8. PubMed ID: 18000488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of 10-year outcome of first-episode psychosis.
    White C; Stirling J; Hopkins R; Morris J; Montague L; Tantam D; Lewis S
    Psychol Med; 2009 Sep; 39(9):1447-56. PubMed ID: 19187566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of family history in first-episode schizophrenia spectrum disorder.
    Norman RM; Manchanda R; Malla AK; Harricharan R; Northcott S
    J Nerv Ment Dis; 2007 Oct; 195(10):846-52. PubMed ID: 18043525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P50 gating at acute and post-acute phases of first-episode schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for emphasis on management over treatment of schizophrenia in clinical practice.
    Ahmed M; Osser DN; Boisvert CM; Albert LG; Aslam M
    Ann Pharmacother; 2007 Apr; 41(4):693-5. PubMed ID: 17389665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between psychopathology of first-episode psychosis patients within the schizophrenia spectrum and previous offending.
    Munkner R; Haastrup S; Joergensen T; Kramp P
    Nord J Psychiatry; 2009; 63(2):124-31. PubMed ID: 19023698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.